EP 83: Daphne Koller, Founder & CEO of Insitro - Integrating machine learning and biology at scale to reimagine drug discovery

August 11th, 2022  |  45 mins 10 secs

drugdiscovery, genetics, insitro, thegeneticspodcast

This week’s guest, Daphne Koller, is the Founder and CEO of Insitro - a company shifting the paradigm of new drug discovery using predictive models.